http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2257424-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2001-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94f4814ef02d5431a14c211071834e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f47aa5644e0bbef016ea62866a714e14 |
| publicationDate | 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2257424-T3 |
| titleOfInvention | DERIVATIVES 4-, 5-, 6- AND 7- OF INDOL USED FOR THE TREATMENT OF CNS DISORDERS |
| abstract | An indolyl derivative substituted with methylene at positions 4, 5, 6 or 7 of formula I wherein R is aryl or heteroaryl, wherein said aryl or heteroaryl group may be substituted one or more times with a substituent selected from halogen, cyano , nitro, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl-C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkyl thio, hydroxy, C1-6 hydroxyalkyl, trifluoromethyl, trifluoromethylsulfonyl, C1-6-sulfonyl alkyl, amino, C1-6-amino alkyl, di (C1-6 alkyl) -amino, acyl, aminocarbonyl and a methylenedioxy group ; X is N, C or CH; provided that the dotted line indicates a link when X is C and not a link when X is N or CH; R 1 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl-C 1-6 alkyl, aryl, C 1-6 arylalkyl, acyl, thioacyl, C1-6-sulfonyl, trifluoromethylsulfonyl or arylsulfonyl alkyl; and R2 and R3 are independently selected from hydrogen, halogen, cyano, nitro, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl-C1- alkyl 6, C1-6 alkoxy, C1-6-thio alkyl, hydroxy, C1-6 hydroxyalkyl, trifluoromethyl, trifluoromethylsulfonyl, C1-6-sulfonyl alkyl, amino, C1-6-amino alkyl, di (alkyl of C1-6) amino, acyl and aminocarbonyl; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2000-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.